Jump to navigation
Domainex is the fastest growing CRO in Europe. By applying our novel proprietary technologies such as CDH and taking a focussed, integrated approach to medicinal chemistry, biochemistry and computational chemistry we can reduce your project timeline by up to 30%.
Domainex has received an award of £118,000 from the UK’s innovation agency, Innovate UK, to develop a new biophysical screening method for G-protein coupled receptors (GPCRs). Here's a short video explaining how the technology works: GPCRs video.
FragmentBuilder: Fragment screening using MicroScale Thermophoresis
Combinatorial Domain Hunting: Protein expression and purification services.
BioassayBuilder: Bioassay services, assay development, HTS and compound testing services.
LeadBuilder: Virtual hit screening platform.
Tweets by Domainex_UK